Uncategorized
VIDEO: Pooled analysis of Rocket studies shows efficacy of Rhopressa
WASHINGTON ― At the American Society of Cataract and Refractive Surgery meeting, Robert Fechtner, MD, discusses the findings of a pooled analysis of more than 800 patients in the Rocket 1, 2 and 4 clinical trials of Aerie Pharmaceuticals’ Rhopressa (netarsudil ophthalmic solution 0.02%) in comparison with timolol.